<DOC>
	<DOCNO>NCT01878266</DOCNO>
	<brief_summary>This Trial offer reduction patient burden , especially preferable child poor compliance poor performance status . This prospective randomize trial extension previous control prospective study perform Children 's Cancer Hospital , Egypt register clinicaltrials.com ( NCT01635140 ) . The ultimate aim work demonstrate noninferiority hypofractionated regimen relative conventional regimen control randomized clinical study .</brief_summary>
	<brief_title>Prospective Trial Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy Diffuse Brainstem Glioma Children</brief_title>
	<detailed_description>In study add third arm increase total dose 4500 cGy 15 fraction 3 week may lead improvement Over-all survival Progression-Free Survival .</detailed_description>
	<mesh_term>Glioma</mesh_term>
	<criteria>1 . Newly diagnose patient diffuse intrinsic brainstem glioma 2 . Aged 218years , 3 . Have symptom less 3 month least two finding neurologic triad : cranial nerve deficit , ataxia , long tract sign . 4 . No performance criterion require entry onto study . Children eligible receive prior therapy steroid Treatment</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Diffuse Intrinsic Pontine Glioma ( DIPG )</keyword>
	<keyword>Hypofractionated Radiotherapy</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Median survival</keyword>
</DOC>